Your browser doesn't support javascript.
loading
[68Ga-PSMA-11 PET/mpMRI for local detection of primary prostate cancer in men with a negative prior biopsy]. / 68Ga-PSMA-11 PET/mpMRT zur Lokaldetektion des primären Prostatakarzinom bei Männern mit negativer Vorbiopsie.
Maurer, Tobias; Gesterkamp, Hannah; Nguyen, Noemi; Westenfelder, Kay; Gschwend, Jürgen E; Budäus, Lars; Rauscher, Isabel; Vag, Tibor; Weber, Wolfgang; Eiber, Matthias.
Affiliation
  • Maurer T; Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Gesterkamp H; Martini-Klinik und Klinik und Poliklinik für Urologie, Universität Hamburg-Eppendorf.
  • Nguyen N; Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Westenfelder K; Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Gschwend JE; Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Budäus L; Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Rauscher I; Martini-Klinik und Klinik und Poliklinik für Urologie, Universität Hamburg-Eppendorf.
  • Vag T; Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Weber W; Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
  • Eiber M; Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
Aktuelle Urol ; 52(2): 143-148, 2021 Apr.
Article in De | MEDLINE | ID: mdl-32854128
INTRODUCTION AND OBJECTIVE: Multiparametric MRI (mpMRI) represents the current gold standard for the detection of primary prostate cancer (PC) after a negative biopsy. PSMA PET imaging has been introduced in the diagnostic work-up of PC with high accuracy, but is currently mainly utilised in the setting of biochemical recurrence. This study aimed to determine the efficacy of combined 68Ga-PSMA-11 PET/mpMRI imaging to detect PC in patients with previously negative prostate biopsies. METHODS: A total of 57 patients who had undergone at least one prior negative prostate biopsy were included in this retrospective analysis. All patients underwent 68Ga-PSMA-11 PET/mpMRI imaging of the prostate. mpMRI was evaluated according to the PIRADS classification system and 68Ga-PSMA-11 PET was rated on a 5-point Likert scale (1: PC highly unlikely; 2: PC unlikely; 3: presence of PC is equivocal; 4: PC likely; 5: PC highly likely). All patients received a systematic random biopsy as well as a targeted transrectal biopsy of lesions suspicious on imaging. Imaging and histological biopsy outcomes were compared on a per-patient basis. RESULTS: In the histological analysis, 35/57 (61.4 %) patients harboured PC lesions. In patients with biopsy-proven PC, 21/35 (60.0 %) had a PI-RADS 4 or 5 lesion on mpMRI and 28 /35 (80.0 %) had a PET rating of 4 or 5. Combined 68Ga-PSMA-11 PET/mpMRI missed only one patient with a Gleason score (GS) 7a tumour (rating of 1 or 2 in both PET and mpMRI). Limitations include the retrospective analysis as well as possible false negative biopsy results even in a fusion biopsy setting. CONCLUSION: In this initial analysis, the combined 68Ga-PSMA-11 PET/mpMRI proved to be a valuable imaging tool to guide prostate biopsies for the detection of PC in patients with a negative prior biopsy. In this approach, 68Ga-PSMA-11 PET and mpMRI show partially complementary findings that enhance the detection of PC lesions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Multiparametric Magnetic Resonance Imaging Type of study: Diagnostic_studies / Observational_studies Limits: Humans / Male Language: De Journal: Aktuelle Urol Year: 2021 Document type: Article Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Multiparametric Magnetic Resonance Imaging Type of study: Diagnostic_studies / Observational_studies Limits: Humans / Male Language: De Journal: Aktuelle Urol Year: 2021 Document type: Article Country of publication: Germany